These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680 [TBL] [Abstract][Full Text] [Related]
49. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects. Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596 [TBL] [Abstract][Full Text] [Related]
50. Histopathology of duodenal mucosal lesions in pediatric patients with inflammatory bowel disease: statistical analysis to identify distinctive features. Hardee S; Alper A; Pashankar DS; Morotti RA Pediatr Dev Pathol; 2014; 17(6):450-4. PubMed ID: 25207874 [TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. Gehlert T; Devergne O; Niedobitek G J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639 [TBL] [Abstract][Full Text] [Related]
52. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. Durno CA; Sherman P; Williams T; Shuckett B; Dupuis A; Griffiths AM J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):170-4. PubMed ID: 10697136 [TBL] [Abstract][Full Text] [Related]
53. Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease. Lee HB; Kim JH; Yim CY; Kim DG; Ahn DS Korean J Intern Med; 1997 Jan; 12(1):7-15. PubMed ID: 9159031 [TBL] [Abstract][Full Text] [Related]
54. Value of counting colonic mucosal Ig-containing cells in the differential diagnosis of chronic inflammatory bowel disease. Seldenrijk CA; Meuwissen SG; Schipper NW; Morson BC; Lindeman J; Meijer CJ J Clin Pathol; 1992 Mar; 45(3):241-7. PubMed ID: 1556234 [TBL] [Abstract][Full Text] [Related]
55. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease. Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483 [TBL] [Abstract][Full Text] [Related]
56. Definition and evaluation of mucosal healing in clinical practice. Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331 [TBL] [Abstract][Full Text] [Related]
57. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Yu YR; Rodriguez JR Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502 [TBL] [Abstract][Full Text] [Related]
58. Focal enhanced gastritis and macrophage microaggregates in the gastric mucosa: potential role in the differential diagnosis between Crohn's disease and ulcerative colitis. Magalhães-Costa MH; Reis BR; Chagas VL; Nunes T; Souza HS; Zaltman C Arq Gastroenterol; 2014; 51(4):276-82. PubMed ID: 25591154 [TBL] [Abstract][Full Text] [Related]
59. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders. Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020 [TBL] [Abstract][Full Text] [Related]